The MWCSD
Sleep Blog
Expert perspectives on sleep medicine, research breakthroughs, and practical advice — written by our board-certified physicians.
Sleep Apnea and Testosterone: Why Treating the Wrong Problem First Can Set You Back
Many men with untreated sleep apnea are prescribed testosterone replacement therapy — but the order matters. Untreated OSA disrupts testosterone at its source, and TRT can worsen sleep apnea. Dr. Vishal Saini explains the science, the sequencing, and what men in Lansing, Traverse City, and Eaton Rapids should know.
When the Treatment Becomes the Problem: What the Latest Research Says About RLS Augmentation
Restless legs syndrome can worsen paradoxically over time on the very medications meant to treat it — a phenomenon called augmentation. Dr. Saini explains the dose escalation trap, why the entire first-line treatment paradigm has been reversed by the 2025 AASM guidelines, and what the current evidence says about getting patients off dopamine agonists safely.
She Felt Better on CPAP. Then She Didn't. Here's Why That's Clinically Important.
Many patients with obstructive sleep apnea feel significantly better on CPAP for the first few months — then the hypersomnia returns, even though the device data looks fine. This isn't a compliance failure. It's a diagnostic signal. Dr. Saini explains the CPAP honeymoon effect, why OSA can mask underlying hypersomnia disorders like narcolepsy type 2 and idiopathic hypersomnia, and what the evidence-based workup looks like when CPAP stops working.
Your Dentist Calls It Grinding. Your Brain Calls It Something Else.
Most people assume sleep bruxism is caused by stress — but the research tells a different story. Sleep bruxism is classified as a sleep movement disorder, driven by brain arousal circuitry, dopamine pathways, and genetics. Dr. Vishal Saini explains what's actually happening in the brain when you grind at night.
Before Starting Xywav or Lumryz, Ask Yourself: How Did Your Body Respond to These Other Medications?
Your prior response to baclofen, gabapentin, or benzodiazepines may reveal meaningful signals about whether Xywav or Lumryz will work for you — but the hierarchy of which drugs matter most as predictors is not what most clinicians assume. Dr. Vishal Saini explains the pharmacological reasoning.
"Benadryl Knocks Me Out Cold" — Does That Mean Pitolisant Will Work Well for You? The Science Says: Not So Fast.
If antihistamines knock you out, does that mean pitolisant will supercharge your wakefulness? The pharmacology says no — and understanding why reveals something important about how narcolepsy and IH affect the histamine system. Dr. Vishal Saini explains the science.
What Your Deep Sleep Percentage Actually Tells Us — And Why It May Predict Whether Oxybate Works for You
Your N3 slow-wave sleep percentage on a sleep study may be one of the most important biomarkers for predicting oxybate response — but the story is fundamentally different for Narcolepsy vs. Idiopathic Hypersomnia. Dr. Vishal Saini explains the emerging science and what it means for your treatment.
MWCSD Now Enrolling: Brilliance Phase III Clinical Trial for Narcolepsy
Mid-West Center for Sleep Disorders is proud to announce the launch of the Brilliance Phase III clinical trial for narcolepsy, sponsored by Alkermes. We are now actively enrolling qualified patients across our Michigan locations.
Introducing The Hidden Sleep Disorders Show
Dr. Vishal Saini launches a new podcast dedicated to uncovering the medical conditions hiding behind unexplained fatigue and poor sleep.
Newsletter
Never miss a new article
Get a quick email whenever we publish new content — no spam, just sleep science.
Ready to Sleep Better?
Reading is a start — but lasting change comes from expert care. Book a consultation with our board-certified sleep physicians.
Book an Appointment